In September, we hosted an in person MS R&D day, which featured two world renowned industry experts, Dr. Francesca Montarolo, Biologist and Leading MS and Nurr1 Target Expert from the Neuroscience ...
5d
NEW YORK, November 7, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and ...
Quarter Results07.11.2024 / 12:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Immunic, Inc. Reports Third Quarter 2024 Financial Resultsand Provides Corporate Update– ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback